Anthracene

Anthracene

SCHEMBL1556441

OBO.c1ccc2cc3ccccc3cc2c1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
CYP2A6 P11509 5/20 0.47
ALOX12 P18054 1/20 0.47
ALDH1A1 P00352 6/20 0.46
HSD17B10 Q99714 4/20 0.46
CYP3A4 P08684 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
CASP1 P29466 2/20 0.46
CASP7 P55210 2/20 0.46
HIF1A Q16665 2/20 0.46
ALOX15 P16050 1/20 0.46
HBB P68871 1/20 0.46
HPGD P15428 3/20 0.45
GLA P06280 2/20 0.45
MAPT P10636 1/20 0.45
ACHE P22303 1/20 0.45
NQO2 P16083 1/20 0.43
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CES2 O00748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthracene SCHEMBL1506810 1.00 CYP1A2 (0.48) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL18037719 0.85 CYP2A6 (0.54) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Naphthalene SCHEMBL215802 0.85 CYP2A6 (0.67) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL2833889 0.84 CYP2A6 (0.64) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL29352043 0.84 CYP2A6 (0.64) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL5713429 0.84 CYP2A6 (0.64) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL7703 0.84 CYP2A6 (0.64) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL25336969 0.82 CYP1A2 (0.40) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL458809 0.81 CYP2A6 (0.50) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10
Anthracene SCHEMBL1395160 0.81 CYP2A6 (0.58) CYP1A2CYP2A6ALOX12ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504771-A Spiropyran derivative with color and fluorescence dual switch, photochromic material, and preparation method and application thereof 安徽省东超科技有限公司 2025-02-25 CN claimed
CN-118878402-A Preparation method of trifluoromethyl ketone compound based on palladium catalysis of C-N bond cleavage 大连理工大学 2024-11-01 CN claimed
CN-118307561-A Photosensitizer for near infrared fluorescence imaging guided photodynamic and photothermal treatment and preparation and application thereof 广东省第二人民医院(广东省卫生应急医院) 2024-07-09 CN claimed
CN-113621215-B Preparation method of organic-inorganic hybrid biomass phenolic resin ablation-resistant material 哈尔滨工业大学 2024-02-09 CN claimed
CN-115677745-A Preparation method of 9-anthraceneboronic acid 中钢集团南京新材料研究院有限公司 2023-02-03 CN claimed
CN-114106050-A Tight chiral environment biphenyl-phenanthrene framework chiral phosphoric acid and preparation method and application thereof 华东理工大学 2022-03-01 CN claimed
EP-1976814-B1 NEW ANTHRACENE DERIVATIVES, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE SAME LG CHEMICAL LTD (KR) 2016-07-13 EP claimed
US-8957407-B2 Anthracene derivatives, preparation method thereof and organic light emitting diode using the same LG CHEM, LTD. (KR) 2015-02-17 US claimed
CN-101374789-B Novel anthracene derivative, method for preparing same, and organic light emitting diode using same LG CHEMICAL LTD 2014-04-30 CN claimed
US-20100252817-A1 New Anthracene Derivatives, Preparation Method Thereof and Organic Light Emitting Diode Using the Same LG CHEM. LTD. (KR) 2010-10-07 US claimed
CN-101374789-A Novel anthracene derivative, method for preparing same, and organic light emitting diode using same LG CHEMICAL LTD (KR) 2009-02-25 CN claimed
EP-1976814-A1 NEW ANTHRACENE DERIVATIVES, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE SAME LG Chem, Ltd. (KR) 2008-10-08 EP claimed
WO-2007086695-A1 NEW ANTHRACENE DERIVATIVES, PREPARATION METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE SAME LG CHEM. LTD. (KR) 2007-08-02 WO claimed
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS PROFUSA INC (US) 2026-02-26 US disclosed
US-12552984-B2 Organic electroluminescent device SFC CO., LTD. (KR) 2026-02-17 US disclosed
US-12492168-B2 Organic material for an electronic optoelectronic device and electronic device comprising the organic material NOVALED GMBH (DE) 2025-12-09 US disclosed
WO-1998022820-A9 DETECTION OF BIOLOGICAL MOLECULES USING BORONATE-BASED CHEMICAL AMPLIFICATION AND OPTICAL SENSORS 1998-09-11 WO disclosed
EP-0862648-A1 DETECTION OF BIOLOGICAL MOLECULES USING CHEMICAL AMPLIFICATION AND OPTICAL SENSORS Minimed Inc. (US) 1998-09-09 EP disclosed
WO-1998022820-A1 DETECTION OF BIOLOGICAL MOLECULES USING BORONATE-BASED CHEMICAL AMPLIFICATION AND OPTICAL SENSORS LAWRENCE LIVERMORE NATIONAL LABORATORY (US) 1998-05-28 WO disclosed
WO-1997019188-A1 DETECTION OF BIOLOGICAL MOLECULES USING CHEMICAL AMPLIFICATION AND OPTICAL SENSORS MINIMED, INC. (US) 1997-05-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552984-B2 Organic electroluminescent device KCNH2, KCNC1, KCNH3 CYP1A2 2550/4885CYP2A6 4032/4885ALOX12 2234/4885
US-12492168-B2 Organic material for an electronic optoelectronic device and electronic device comprising the organic material OCIAD1, OCIAD2, OR10J3 CYP1A2 1859/4885CYP2A6 2970/4885ALOX12 189/4885
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS INSR, IRS1, SLC2A4 CYP1A2 3737/4885CYP2A6 2907/4885ALOX12 3458/4885
US-20100252817-A1 New Anthracene Derivatives, Preparation Method Thereof and Organic Light Emitting Diode Using the Same CYBA, XPOT, TOMM22 CYP1A2 33/4885CYP2A6 282/4885ALOX12 364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.